Live Chat ×
Skip to main content

The Brave New World of Head and Neck Pathology: Updates on the WHO and More




Evaluated by: 
David B. Kaminsky, M.D., FIAC, June 2, 2018
Original release date:  July 3, 2018
Access to this course expires on:  June 2, 2021
CME 12.5
SAMs 12

Course Description
Head and neck pathology represents a significant portion of surgical pathology practice. Studies have shown this area to be particularly treacherous for community pathologists, with up to 53% of diagnoses changed (including 7% with major changes) upon second review at tertiary care hospitals.

Complicating this inherent difficulty, there have been numerous recent developments in the field of head and neck pathology. Novel entities have been described, pathognomonic molecular alterations have been uncovered, and major shifts in diagnostic classification schemes have been proposed. Many of these concepts were incorporated into the newest editions of the WHO Classifications for Head and Neck and Endocrine Tumors, both of which were published this year.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

  • Develop a diagnostic approach to the encapsulated follicular-patterned thyroid nodule 
  • Develop a diagnostic approach to the "small round blue cell" sinonasal tumor 
  • Describe the algorithmic approach to HPV testing in a head and neck cancer 
  • Recognize the updated WHO terminology of salivary gland carcinomas 
  • Recognize the appropriate WHO grading scheme for squamous dysplasia in the larynx  

Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Continuous Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 12 SAM credit hours.

Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships:  Justin Bishop, M.D., Justine A. Barletta, M.D., Roderick H.W. Simpson, Bsc, MB ChB, MMed (Anat Path), FRCPC, Raja R. Seethala, M.D.

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.

Buy the entire The Brave New World of Head and Neck Pathology: Updates on the WHO and More course and get a great discount!

Not A Member? Click Here